Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Makoto Isono(Heinrich Heine University Düsseldorf), Wolfgang A. Schulz(Heinrich Heine University Düsseldorf)
Cited by 81
Related Papers
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells
|Anticancer Research|2018|24
Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
|Scientific Reports|2021|22
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
|Anticancer Research|2018|11